BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28622443)

  • 1. miR-2909 regulates ISGylation system via STAT1 signalling through negative regulation of SOCS3 in prostate cancer.
    Ayub SG; Kaul D
    Andrology; 2017 Jul; 5(4):790-797. PubMed ID: 28622443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.
    Kneitz B; Krebs M; Kalogirou C; Schubert M; Joniau S; van Poppel H; Lerut E; Kneitz S; Scholz CJ; Ströbel P; Gessler M; Riedmiller H; Spahn M
    Cancer Res; 2014 May; 74(9):2591-603. PubMed ID: 24607843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An androgen-regulated miR-2909 modulates TGFβ signalling through AR/miR-2909 axis in prostate cancer.
    Ayub SG; Kaul D; Ayub T
    Gene; 2017 Oct; 631():1-9. PubMed ID: 28754634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, regulation and function of the ISGylation system in prostate cancer.
    Kiessling A; Hogrefe C; Erb S; Bobach C; Fuessel S; Wessjohann L; Seliger B
    Oncogene; 2009 Jul; 28(28):2606-20. PubMed ID: 19430494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1.
    Krebs M; Behrmann C; Kalogirou C; Sokolakis I; Kneitz S; Kruithof-de Julio M; Zoni E; Rech A; Schilling B; Kübler H; Spahn M; Kneitz B
    Biomed Res Int; 2019; 2019():6392748. PubMed ID: 31828111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
    McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
    Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased miR-187 induces retinal ganglion cell apoptosis through upregulating SMAD7 in glaucoma.
    Zhang QL; Wang W; Li J; Tian SY; Zhang TZ
    Biomed Pharmacother; 2015 Oct; 75():19-25. PubMed ID: 26463627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
    Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
    Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
    Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
    Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-β Pathway.
    Fang LL; Sun BF; Huang LR; Yuan HB; Zhang S; Chen J; Yu ZJ; Luo H
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
    Weng H; Mertens PR; Gressner AM; Dooley S
    J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β induced miR-132 enhances the activation of TGF-β signaling through inhibiting SMAD7 expression in glioma cells.
    Wang ZH; Zhang QS; Duan YL; Zhang JL; Li GF; Zheng DL
    Biochem Biophys Res Commun; 2015 Jul; 463(3):187-92. PubMed ID: 25983322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2201-2210. PubMed ID: 28741117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.
    Ulloa L; Doody J; Massagué J
    Nature; 1999 Feb; 397(6721):710-3. PubMed ID: 10067896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7.
    Liu J; Zhou Y; Shi Z; Hu Y; Meng T; Zhang X; Zhang S; Zhang J
    DNA Cell Biol; 2016 Sep; 35(9):521-9. PubMed ID: 27303812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
    Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A
    Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.